INTRODUCTION
Unlike other epithelial surfaces in the body, the intestinal epithelium is exposed to a high concentration of bacteria and bacterial products. 1, 2 This situation is particularly true in the colon where there is an estimated 10 14 bacteria per gram of tissue. In spite of the density of commensal bacteria in the colon, the normal intestinal mucosa maintains a controlled state of inflammation characterized by lamina propria lymphocytes, macrophages and dendritic cells in the absence of neutrophils. In patients with idiopathic inflammatory bowel disease, however, the intestinal mucosal immune system generates an overly aggressive immune response in the presence of bacteria resulting in intestinal epithelial cell damage, ulcerations, and diarrhea. 3, 4 A delicate balance exists between the human host and the intestinal microbiota. Understanding this delicate balance may provide clues to situations in which the balance is disturbed such as inflammatory bowel disease. Colonic epithelial cells form a relatively impermeable monolayer held together by tight junctions, occludins junctions and claudins that do not permit the passage of LPS or bacteria. 5 Although an important function of the intestinal epithelium is to form a barrier, the epithelium is also an active participant in the mucosal immune response, especially to pathogenic bacteria, through its secretion of chemokines such as IL-8. 6, 7 In health, the combination of an impermeable epithelial barrier and controlled antigen presentation results in a state of tolerance to autologous commensal flora. 4, 8, 9 By contrast, patients with inflammatory bowel disease are characterized by an abnormal immune response to commensal flora, 4 
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The intestinal epithelium provides a critical interface between lumenal bacteria and the mucosal immune system. Whereas normal commensal flora do not trigger acute inflammation, pathogenic bacteria trigger a potent inflammatory response. Our studies emanate from the hypothesis that the intestinal epithelium is normally hyporesponsive to commensal pathogen-associated molecular patterns (PAMPs) such as LPS. Our data demonstrate that normal human colonic epithelial cells and lamina propria cells express low levels of TLR4 and its co-receptor MD-2. This expression pattern is mirrored by intestinal epithelial cell (IEC) lines. Co-expression of TLR4 and MD-2 is necessary and sufficient for LPS responsiveness in IEC. Moreover, LPS sensing occurs along the basolateral membrane of polarized IEC in culture. Expression of MD-2 is regulated by IFN-g. Cloning of the MD-2 promoter demonstrates that promoter activity is increased by IFN-g and blocked by the STAT inhibitor SOCS3. We conclude from our studies that the intestinal epithelium down-regulates expression of TLR4 and MD-2 and is LPS unresponsive. The Th1 cytokine IFN-g up-regulates expression of MD-2 in a STAT-dependent fashion. The results of our studies have important implications for understanding human inflammatory bowel diseases. stream, 10, 11 and a response to antibiotic therapy. 12, 13 These data suggest that tolerance to the commensal flora is disturbed either as a cause or consequence of intestinal inflammation.
Our research emanates from the hypothesis that the normal intestinal epithelium is hyporesponsive to lumenal bacteria and their products. We reasoned that a pro-inflammatory response to commensal bacteria would be deleterious to the host. To this end, we have chosen to characterize the response of the intestinal epithelium to LPS because Gramnegative anaerobes and Gram-negative aerobes such as Escherichia coli make up the majority of bacteria by weight in the colon. 14 We and others have previously described that intestinal epithelial cells are unresponsive to purified, protein-free lipopolysaccharide (LPS) as measured by NF-kB activation and IL-8 secretion. 15, 16 The reason for LPS unresponsiveness in intestinal epithelial cell lines is low expression of Toll-like receptor 4 (TLR4) and its co-receptor MD-2. 15 Expression of both TLR4 and MD-2 restores the ability of intestinal epithelial cells to respond to LPS suggesting that the intracellular signaling pathway leading to NF-kB is intact in these cells. In data presented here, we extend our initial observations in intestinal epithelial cell lines to normal human intestine and its lamina propria. We also characterize the polarity of the response to LPS and the promoter for the TLR4 co-receptor MD-2. The results of our studies have important implications for the understanding of host-microbial interactions in the gut.
MATERIALS AND METHODS

Cells and reagents
Intestinal epithelial cell lines Caco-2, HT-29 and T84 were obtained from the American Type Culture Collection (Rockville, MD, USA). The immortalized human dermal endothelial cells (HMEC) were a generous gift of Dr Candal (Center for Disease Control and Prevention, Atlanta, GA, USA). 17 Culture conditions have been described previously. [18] [19] [20] For experiments in which polarized T84 monolayers were used, transepithelial resistance (TER) was measured using a Millipore Millicell-ERS Voltohmeter. Experiments were performed when TER was > 2000 ohm-cm 2 . 21 Highly purified, phenol-water-extracted E. coli K235 LPS (< 0.008% protein), which was prepared according to the method of McIntire et al., 22 was obtained from Stefanie N. Vogel (Uniformed Services University of the Health Sciences, Bethesda, MD, USA). 23, 24 Human IL-1b and TNF-a were purchased from R&D Systems (Minneapolis, MN, USA).
Expression vectors and cDNA constructs
ELAM-NF-kB luciferase 25 and pCMV-EGFP (Clontech) 26 were used as previously described. Human IL-8 promoter-luciferase construct was kindly provided by Dr N. Mukaida. 27 A FLAG-tagged human TLR4 construct was obtained from Tularik (San Francisco, CA, USA). MD-2 cDNA construct was kindly provided by D. Kensuke Miyake (Saga Medical School, Saga, Japan). 28 IRF-1/3X-GAS-luciferase was kindly provided by Dr Richard Jove (Moffitt Cancer Center and Research, Tampa, FL, USA). 29 The SOCS3 expression vector was kindly provided by Dr Douglas Hilton (The Walter and Eliza Hall Institute of Medical Research and Cooperative Research Centre for Cellular Growth Factors, Post Office, Royal Melbourne Hospital, Victoria 3050, Australia). 30 Plasmids were prepared with the endotoxin-free Plasmid Maxi-prep kit (Qiagen, Valencia, CA, USA). Transfection methodology and read-out systems for the respective cell lines have been described previously. [18] [19] [20] 
MD-2 promoter studies
Genbank was searched for human MD-2 and yielded two accession numbers. The MD-2 gene is located on the minus strand of chromosome 8. Accession number NT_008209 (contig) was used to identify 1 kb of sequence upstream of the start site and AC009672 was used to identify 2 kb of sequence upstream of the start site. The following primers were designed to amplify a 1013 bp sequence (-1 kB) and a 2042 bp sequence (-2 kB) upstream of the ATG start site: Primer 1 GCTTTACAAATGCAAAGAGGATCAG (same primer for both -1 kB and -2 kB); -1 kB = primer 2 reverse CATGGCCTGTTAGGAATCTGGT; -2 kB = primer 3 reverse GGCTGCTAACCCTAAGCTATATCC. Human genomic DNA was used to amplify the respective sequences. PCR products were cloned into pCR 2.1 TOPO vector and inserts sequenced using M13 forward and reverse primers. After confirmation of the correct sequence, inserts were directionally cloned into the pGL3 basic luciferase reporter vector (Promega).
Reverse transcription-polymerase chain reaction (RT-PCR) analysis and laser capture microscopy
Generation of RNA, cDNA and PCR is as previously described. [18] [19] [20] Frozen sections derived from human intestinal resections were obtained with the approval of the Cedars-Sinai Medical Center Institutional Review Board. The tissue used for this study included uninvolved areas of intestine from patients with inflammatory bowel disease or colon cancer. Slides were gently fixed in 100% ethanol followed by a light hematoxylin and eosin staining. An Arcturus laser capture microscope was used to microsdissect the tissue. Briefly, intestinal epithelial cells were identified based on appearance and location, microdissected and captured on a microfuge cap. Lamina propria was separately microdissected and captured from each intestinal specimen. Photographic documentation was obtained before and after dissection. Total RNA was made by incubating cells at -80°C overnight in lysis buffer containing Tris-HCl 50 mM (pH 8.0), NaCl 100 mM, MgCl 2 5 mM, Triton X-100 0.5%, DTT 1 mM and RNase inhibitor at 1000 U/ml. After lysis and centrifugation, total RNA was followed directly by reverse transcription using random hexamers and Superscript II (Gibco/BRL). The cDNA generated was amplified with the following primers: for b-actin (LB08: GGCTACAGCTTCACCACCACG; LB09: GCCAGACAGCAGTGTGTTGGC), TLR4 (TLRF P1: 5¢-GCTTCTTGCTGGCTGCATAA-3¢; TLRF P2: 5¢-GAAATGGAGGCACCCCTTC-3¢) and MD-2 (MD-2F P1: 5¢-GCAGAGCTCTGAAGGGAGAGACT-3¢; MD-2F P2 5¢-GGTTGGTGTAGGATGACATCC-3¢).
ELISA and Western blotting TLR4 Western blots were performed using standard methodology 31 with anti-human TLR4 antibody (Santa Cruz; 1:250) followed by incubation with anti-rabbit HRP (1:2000) . Human IL-8 ELISA was performed as previously described. 32 
RESULTS
Intestinal epithelial cells express low levels of TLR4 and MD-2 and are poorly responsive to LPS
We hypothesized that normal colonic epithelial cells do not generate a pro-inflammatory response in the presence of bacteria or bacterial products. To test this hypothesis, we began by examining the expression of TLR4 and its co-receptor MD-2 in the intestinal epithelium. Our data demonstrate that normal colonic epithelial cells isolated from surgical resections using laser capture microdissection do not express MD-2 and express low levels of TLR4 (Fig. 1A,B ). 18 This situation is mirrored in colonic epithelial cell lines which also do not express MD-2 and expressed very low levels of TLR4 (Fig. 1C ). 19 For this reason, we believe that these intestinal epithelial cell lines serve as appropriate models in which to explore the functional responses of colonic epithelial cells in vitro.
We next explored the responses of well-characterized intestinal epithelial cell lines to LPS. Our read-out for LPS responsiveness was transcriptional activation of NF-kB, transcriptional activation of the IL-8 promoter and secretion of IL-8 by intestinal epithelial cells. 19 We chose these assays because they reflect part of the normal spectrum of pro-inflammatory responses in the intestinal epithelium that correlate with inflammatory conditions such as inflammatory bowel disease or infectious colitis. 33 The data demonstrated that purified, protein-free LPS does not result in significant NF-kB activation (Fig. 2) or IL-8 secretion (data not shown) in these intestinal epithelial cell lines. Co-transfection of TLR4 and MD-2 permitted LPS responsiveness in these cells supporting the idea that deficient TLR4 and MD-2 expression is responsible for LPS unresponsiveness.
LPS responsiveness is localized to the basolateral epithelium of polarized intestinal epithelial monolayers
We have shown that intestinal epithelial cells are poorly responsive to LPS but that transgenic expression of TLR4 and MD-2 restores LPS-responsiveness. TLR5, another member of the TLR family, recognizes flagellin and is expressed on the basolateral membrane of intestinal epithelial cells. 34, 35 We hypothesized that recognition of LPS by intestinal epithelial cells occurred predominantly along the basolateral surface of intestinal epithelial cells, a surface not normally exposed to bacteria. To test this hypothesis, we transfected T84 cells with TLR4 and MD-2 and cultured these in transwells. T84 cells are a colonic crypt-like epithelial cell line that recapitulate many of the normal transport functions of the intestinal epithelium. 36 Experiments were performed when transepithelial resistance (TER) was > 2000 ohm-cm 2 . The data demonstrate that expression of TLR4 and MD-2 restore LPS responsiveness and this responsiveness is localized to the basolateral membrane (Fig. 2) . These data suggest that expression of TLR4, MD-2 or both is polarized to the basolateral membrane in intestinal epithelial cells.
Th1 cytokines up-regulate expression of TLR4 and MD-2 in intestinal epithelial cells
We next turned our attention to the regulation of TLR4 and MD-2 expression in the inflamed epithelium. Idiopathic inflammatory bowel disease is characterized by an over-production of the Th1 cytokine IFN-g and the macrophage-derived cytokine TNF-a. 37, 38 Interferonconsensus sequences had been identified in the TLR4 promoter 39 and we had previously found that IFN-g stimulated TLR4 expression in endothelial cells. 40 We hypothesized that these cytokines would regulate both the expression and function of the TLR complex in intestinal epithelial cells. Our data demonstrate that IFNg stimulated TLR4 and MD-2 expression in HT-29 cells, a colonocyte-like intestinal epithelial cell line (Fig. 3 ). TNF-a alone or in combination with IFN-g had little effect on TLR4 or MD-2 expression in HT-29 cells. In T84 cells, IFN-g led to an increase in expression of MD-2 whereas TNF-a modestly increased expression of TLR4. Stimulation of HT-29 cells with TNF-a resulted in enhanced IL-8 production in response to LPS (data not shown). We conclude from these studies that Th1 cytokines differentially regulated the expression of TLR4 and MD-2 in intestinal epithelial cells in vitro and TLR signaling at the intestinal epithelial interface 325 speculate that the response of intestinal epithelial cells to cytokines in vivo may be regulated differentially along the crypt-to-villus axis.
IFN-g regulates the MD-2 promoter in a STATdependent fashion
The consistent observation from these studies was that IFN-g induced MD-2 expression in intestinal epithelial cell lines. Little is known about the regulation of MD-2 expression in either immune or non-immune cells. In order to better understand the regulation of MD-2, we cloned a 2000 bp fragment of the MD-2 promoter upstream of the translational start site and placed this fragment upstream of a luciferase gene. We hypothesized that the level of MD-2 expression was regulated by differential transcriptional activation of the MD-2 promoter. Given our finding that IFN-g increased expression of MD-2 mRNA, we reasoned that IFN-g might regulate expression of the MD-2 promoter. We further reasoned that IFN-g-dependent signaling was mediated by activation of the JAK-STAT pathway in intestinal epithelial cells. To address these questions, we expressed the MD-2 promoter in intestinal epithelial cells and stimulated these with IFN-g. Stimulation with IFN-g resulted in 100-fold increase over the empty vector control and a 70-fold increase over the unstimulated MD-2 promoterluciferase construct (Fig. 4) . Expression of a STAT inhibitor, SOCS3, blocked IFN-g-mediated increase in MD-2 promoter activity (Fig. 5) . These data suggest that the MD-2 promoter contains an IFN-g-inducible element such as a STAT binding site. This site lies within 1 kB of the translational start site.
To identify the region of the MD-2 promoter which is IFN-g responsive, we have developed deletion mutants of the MD-2 promoter and tested the ability of these mutants to direct luciferase expression in response to IFN-g. Our data demonstrate that loss of the -1000 bp Fig. 3 . Expression of TLR4 and MD-2 in response to cytokine stimulation of intestinal epithelial cells. HT-29 cells (left) or T84 cells (right) were exposed to IFN-g (I) 40 ng/ml, TNF-a (T) 20 ng/ml singly or both (B) for the indicated times. Unstimulated HT-29 or T84 cells were used as a control (C). b-Actin (bottom panel) was analyzed to verify similar cDNA loading. Expression of TLR4 (150 bp) and MD-2 (150 bp) were analyzed by PCR following reverse transcription of mRNA from IEC as indicated. TLR4 mRNA is increased in HT-29 cells in response to IFN-g and is maximal at 18 h. TNF-a led to a modest increase in TLR4 mRNA in T84 cells. Both cell lines demonstrate an increase in MD-2 mRNA following IFN-g induction. This is one representative experiment of three with similar results. Fig. 4 . The MD-2 promoter is activated by IFN-g in intestinal epithelial cells. T84 cells were transfected with constructs containing a 1 kB (1 kB-MD-2 pGL3) or 2 kB (2 kB-MD-2 pGL3) fragment of the MD-2 promoter upstream of the luciferase gene or the empty pGL3 vector control and a bgalactosidase expression vector. The day following transfection, T84 cells were stimulated with IFN-g for 5 h as indicated and cells lysed for luciferase and b-galactosidase measurements. Stimulation of 1 kB-MD-2 pGL3 or 2 kB-MD-2 pGL3 with IFN-g significantly increased reporter gene activation in T84 cells, P = 0.005 and P = 0.001, respectively. Stimulation of 1 kB-MD-2 pGL3 with IFN-a significantly increased reporter gene activation in T84 cells, P = 0.008 but not the 2 kB-MD-2 pGL3 reporter gene P = 0.14. This graph is one experiment representative of three with similar findings and was performed in triplicate. Error bars indicate standard deviation. and -700 bp region of the promoter resulted in absence of IFN-g inducibility of the MD-2 promoter (Fig. 6 ). Basal promoter activity was not lost. These data suggest that this region contains binding sites for IFN-ginducible factors.
DISCUSSION
The intestinal epithelium faces a daunting task. On the one hand it must suppress an inflammatory response to harmless commensal flora while on the other hand be poised to fight off invading pathogenic bacteria. Tipping the balance in either direction could prove deleterious to the host. Both human studies and animal models of inflammatory bowel disease support a role for disturbed host-microbial interactions in the pathogenesis of inflammatory bowel disease. [41] [42] [43] [44] Several lines of data support an inappropriate immune response to the presence of commensal flora in patients with inflammatory bowel disease. 4, [45] [46] [47] [48] [49] [50] [51] The recent identification of mutations in the NOD2 gene in patients with Crohn's disease lends further support for this concept. [52] [53] [54] The results of our studies 18, 19 and the studies of others 16, 55 have shed light on the mechanisms by which intestinal epithelial cells protect against chronic, pro-inflammatory gene expression in the presence of commensal bacteria.
Many have debated whether commensal bacteria are good or bad in the pathogenesis of inflammatory bowel disease. Patients with inflammatory bowel disease experience a diversity of clinical manifestations from purely colonic inflammation to severe small intestinal inflammation. It is likely, therefore, that specific etiologic agents (bacteria, viruses) may be responsible for eliciting inflammation in a subset of patients whereas normal commensal flora may be sufficient to trigger inflammation in others. A recent study characterizes the microbial flora in patients with inflammatory bowel disease. 56 This TLR signaling at the intestinal epithelial interface 327 Fig. 5 . IFN-g regulates MD-2 promoter activity through the JAK-STAT pathway. T84 cells were transfected with 1 kB-MD-2 pGL3 or the empty pGL3 vector control and a b-galactosidase expression vector and co-transfected with an expression vector for SOCS3, a STAT inhibitor, or its empty vector control. The day following transfection, T84 cells were stimulated with IFN-g 40 ng/ml for 5 h as indicated and cells lysed for luciferase and b-galactosidase measurements. Stimulation with IFN-g significantly increased reporter gene activation in T84 cells and this activation was blocked by 80% in cells cotransfected with SOCS3, P < 0.01. This graph is one experiment representative of three with similar findings and was performed in triplicate. Error bars indicate standard deviation.
Fig. 6.
Cloning and characterization of the -1 kB fragment of the MD-2 promoter using deletion mutants. Top panel demonstrates cloning of deletion mutants within the -1 kB fragment of the MD-2 gene promoter using primers flanked by the arrows. Bottom panel demonstrates transfection of T84 cells with 1 kB-MD-2 pGL3 or deletion mutants as indicated. The day following transfection, T84 cells were stimulated with IFN-g 40 ng/ml for 5 h as indicated and cells lysed for luciferase and b-galactosidase measurements. Reporter gene activation was significantly higher in cells transfected with 1 kB-MD-2 pGL3 or the mutants compared with the empty pGL3 vector control (data not shown). Stimulation with IFN-g significantly increased 1 kB-MD-2 pGL3 reporter gene activation in T84 cells. This IFN-g-dependent activation was abrogated with deletion of the 728 to -1 kB region. This graph is one experiment representative of three with similar findings and was performed in triplicate. Error bars indicate standard deviation. study found a dramatic increase in the number of bacteria adherent to the intestinal epithelium in inflammatory bowel disease mucosa. The increase in adherent bacteria occurred even in mucosa that was not inflamed suggesting that frank perturbations in the mucosal lining were not required. The adherent bacteria were diverse and similar to those found in the healthy controls. These data suggest that epithelial factors may play an important role in the adherence of bacteria and that the intestinal epithelium in an inflammatory milieu may permit the adherence of an abnormally high number of bacteria.
Our studies have found that intestinal epithelial cells go to great lengths to avoid a response to lumenal bacterial products. These cells have very low levels of TLR4 and MD-2 expression and are poorly LPS responsive. 18, 19 Even in the setting of cytokine stimulation and an increase in TLR4 and MD-2 expression, the response to LPS as measured by IL-8 secretion is quite modest when compared to a potent stimulus such as TNF-a. We believe part of the explanation lies in the transcriptional regulation of TLR4 and MD-2. The finding of low mRNA expression of TLR4 and MD-2 by intestinal epithelial cells isolated from colonic surgical resections corroborates our initial findings in intestinal epithelial cell lines. Thus we have focused on characterizing the promoter for MD-2. We have identified a region that appears to contain an IFN-g responsive element. Future studies will address whether this region contains a STAT binding site and a potential point of intervention in TLR4 complex regulation.
Our studies suggest that intestinal epithelial cells have an otherwise intact TLR/IL-1R intracellular signaling pathway (Fig. 7) . Co-ordinated expression of TLR4 and MD-2 is all that is required to restore the ability of intestinal epithelial cells to respond to LPS. In the setting of pathogenic bacteria, NF-kB is activated when the intestinal epithelial cell has been invaded. [57] [58] [59] [60] It is not clear whether LPS from pathogenic bacteria alone is sufficient to activate a pro-inflammatory response by intestinal epithelial cells. We believe there is co-operation between the adaptive immune system in the intestine and the innate immune system composed of the intestinal epithelial cells and lamina propria macrophages in the clearance of pathogenic bacteria. One model for this would be the production of Th1 cytokines by lamina propria mononuclear cells which then increase expression of TLR4 and MD-2 by intestinal epithelial cells and invoke their help in the clearance of pathogens. (Fig. 7, right panel) The results of these studies may shed light on normal homeostatic mechanisms regulating bacterial recognition in the gut and their derangement in inflammatory bowel disease.
